LCN2 and stroke disorder: Since LCN2 was induced in cerebral endothelial cells and astrocytes gatekeeping the BBB after tMCAo (Figure 1 and Figure 2), we assessed the effectiveness of LCN2 mAb to treat the BBB disruption after stroke (Figure 5).